$DNMR
Danimer Scientific, Inc. Stock $dnmr

$dnmr Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-K Financial Statement

#000095017022003031 Filed on March 08, 2022

Income Statement

Concept	2022 Q1	2021 Q3	2021
Revenue	$14.74M	$13.37M	$58.75M
YoY Change	11.85%	4.16%	24.12%
Cost Of Revenue	$16.07M	$13.60M	$57.87M
YoY Change	37.01%	48.03%	61.29%
Gross Profit	-$1.322M	-$232.0K	$884.0K
YoY Change	-190.8%	-106.36%	-92.28%
Gross Profit Margin	-8.97%	-1.74%	1.5%
Selling, General & Admin	$22.24M	$26.59M	$80.00M
YoY Change	119.72%	689.08%	313.61%
% of Gross Profit			9050.23%
Research & Development	$7.131M	$5.010M	$20.27M
YoY Change	172.28%	128.77%	158.18%
% of Gross Profit			2292.99%
Depreciation & Amortization	$4.259M	$3.178M	$11.67M
YoY Change	102.81%		153.23%
% of Gross Profit			1320.59%
Operating Expenses	$29.37M	$31.60M	$100.3M
YoY Change	130.53%	468.38%	268.74%
Operating Profit	-$30.69M	-$31.83M	-$99.47M
YoY Change	171.99%	1564.09%	532.45%
Interest Expense	$992.0K	$246.0K	$27.00M
YoY Change	570.27%	-26.35%	1546.59%
% of Operating Profit
Other Income/Expense, Net	$4.012M	$28.24M	$26.13M
YoY Change	-104.81%	-12593.81%	280.1%
Pretax Income	-$26.68M	-$3.598M	-$73.34M
YoY Change	-71.84%	68.21%	728.42%
Income Tax	-$291.0K	$11.42M	-$13.23M
% Of Pretax Income
Net Earnings	-$26.39M	$7.825M	-$60.11M
YoY Change	-72.15%	-465.83%	578.94%
Net Earnings / Revenue	-178.97%	58.53%	-102.31%
Basic Earnings Per Share	-$0.26	$0.08
Diluted Earnings Per Share	-$262.0K	$0.08	-$645.8K
COMMON SHARES
Basic Shares Outstanding	100.8M	98.16M	93.08M
Diluted Shares Outstanding	100.7M	103.5M	93.08M

Balance Sheet

Concept	2022 Q1	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$210.0M	$194.2M	$286.5M
YoY Change	-32.87%	-3.61%	-24.13%
Cash & Equivalents	$210.0M	$194.2M	$286.5M
Short-Term Investments
Other Short-Term Assets	$4.059M	$3.553M	$4.737M
YoY Change	-11.76%	3453.0%	52.81%
Inventory	$28.23M	$24.15M	$24.57M
Prepaid Expenses	$4.059M	$3.553M
Receivables	$18.83M	$12.83M	$20.73M
Other Receivables	$1.378M	$1.073M	$3.836M
Total Short-Term Assets	$266.8M	$238.9M	$340.4M
YoY Change	-22.84%	18.49%	-15.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$364.6M	$222.5M	$335.4M
YoY Change	181.4%		165.79%
Goodwill	$62.66M	$66.58M
YoY Change
Intangibles	$83.58M	$86.66M
YoY Change	4637.98%
Long-Term Investments
YoY Change
Other Assets	$228.0K	$146.0K	$2.102M
YoY Change	212.33%		-12.42%
Total Long-Term Assets	$545.6M	$411.4M	$498.2M
YoY Change	227.76%		246.48%
TOTAL ASSETS
Total Short-Term Assets	$266.8M	$238.9M	$340.4M
Total Long-Term Assets	$545.6M	$411.4M	$498.2M
Total Assets	$812.5M	$650.2M	$838.6M
YoY Change	58.59%	222.54%	53.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.08M	$20.38M	$20.79M
YoY Change	58.16%		96.13%
Accrued Expenses	$14.04M	$8.561M	$22.11M
YoY Change	83.51%	8461.0%	81.26%
Deferred Revenue		$233.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$218.0K	$334.0K	$357.0K
YoY Change	-36.81%		-98.58%
Total Short-Term Liabilities	$34.67M	$32.45M	$43.48M
YoY Change	43.35%	32354.0%	-13.91%
LONG-TERM LIABILITIES
Long-Term Debt	$261.5M	$29.54M	$260.9M
YoY Change	734.91%		731.0%
Other Long-Term Liabilities	$526.0K	$1.072M	$32.91M
YoY Change	-43.92%	-84.0%	-69.61%
Total Long-Term Liabilities	$526.0K	$30.61M	$293.8M
YoY Change	-98.37%	356.84%	110.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.67M	$32.45M	$43.48M
Total Long-Term Liabilities	$526.0K	$30.61M	$293.8M
Total Liabilities	$324.5M	$121.2M	$338.3M
YoY Change	41.08%	1681.82%	77.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$145.3M	-$106.4M
YoY Change	-5.37%
Common Stock	$10.00K	$10.00K
YoY Change	11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$487.9M	$529.1M	$500.3M
YoY Change
Total Liabilities & Shareholders Equity	$812.5M	$650.2M	$838.6M
YoY Change	58.59%	222.54%	53.53%

Cashflow Statement

Concept	2022 Q1	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	-$26.39M	$7.825M	-$60.11M
YoY Change	-72.15%	-465.83%	578.94%
Depreciation, Depletion And Amortization	$4.259M	$3.178M	$11.67M
YoY Change	102.81%		153.23%
Cash From Operating Activities	-$17.61M	-$24.80M	-$62.96M
YoY Change	23.91%	8757.14%	356.35%
INVESTING ACTIVITIES
Capital Expenditures	$58.90M	-$44.89M	$185.4M
YoY Change	146.52%		384.51%
Acquisitions	$14.00K		$151.2M
YoY Change
Other Investing Activities	-$14.00K	-$151.2M	-$150.8M
YoY Change			-1507670.0%
Cash From Investing Activities	-$58.92M	-$196.1M	-$336.2M
YoY Change	146.58%		778.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$890.0K
YoY Change			-102.74%
Debt Paid & Issued, Net	$44.00K		$27.16M
YoY Change	-99.84%		1299.38%
Cash From Financing Activities	78.00K	289.0K	306.2M
YoY Change	-100.29%		-27.56%
NET CHANGE
Cash From Operating Activities	-17.61M	-24.80M	-62.96M
Cash From Investing Activities	-58.92M	-196.1M	-336.2M
Cash From Financing Activities	78.00K	289.0K	306.2M
Net Change In Cash	-76.44M	-220.6M	-92.93M
YoY Change	18.21%	78679.29%	-125.07%
FREE CASH FLOW
Cash From Operating Activities	-$17.61M	-$24.80M	-$62.96M
Capital Expenditures	$58.90M	-$44.89M	$185.4M
Free Cash Flow	-$76.51M	$20.09M	-$248.4M
YoY Change	100.8%		377.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense
CY2019	dnmr	Transaction Costs In Accounts Payable And Accrued Expenses TransactionCostsInAccountsPayableAndAccruedExpenses
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2020	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities
CY2021	dnmr	Forgiveness Of Nmtc Leverage Loan Receivable ForgivenessOfNmtcLeverageLoanReceivable
CY2019	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001779020
CY2021	dnmr	Private Warrant Liability Assumed In Business Combination PrivateWarrantLiabilityAssumedInBusinessCombination
CY2019	dnmr	Private Warrant Liability Assumed In Business Combination PrivateWarrantLiabilityAssumedInBusinessCombination
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2021	dnmr	Transaction Costs In Accounts Payable And Accrued Expenses TransactionCostsInAccountsPayableAndAccruedExpenses
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustments Related To Previous Period BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2019	dnmr	Accounts Payable Settled Directly By Landlord AccountsPayableSettledDirectlyByLandlord
CY2021	dnmr	Accounts Payable Settled Directly By Landlord AccountsPayableSettledDirectlyByLandlord
CY2021Q4	dnmr	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Contingent Purchase Price Payable BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentPurchasePricePayable
CY2019	dnmr	Income Tax Reconciliation Deductions Transaction Costs Associated With The Business Combination IncomeTaxReconciliationDeductionsTransactionCostsAssociatedWithTheBusinessCombination
CY2021Q4	dnmr	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Cash And Restricted Cash BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndRestrictedCash
CY2019Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39280
CY2021	dei	Entity Registrant Name EntityRegistrantName	DANIMER SCIENTIFIC, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1924518
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	140 Industrial Boulevard
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Bainbridge
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	39817
CY2021	dei	City Area Code CityAreaCode	229
CY2021	dei	Local Phone Number LocalPhoneNumber	243-7075
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	2198000000
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	100750215
CY2021	dei	Auditor Firm AuditorFirmId	185
CY2021	dei	Auditor Name AuditorName	KPMG LLP
CY2021	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	286487000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	377581000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17149000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6605000
CY2021Q4	us-gaap	Other Receivables OtherReceivables	3836000
CY2020Q4	us-gaap	Other Receivables OtherReceivables	0
CY2021Q4	us-gaap	Inventory Net InventoryNet	24573000
CY2020Q4	us-gaap	Inventory Net InventoryNet	13642000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4737000
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3089000
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3576000
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1466000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	340358000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	402383000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	316181000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106795000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	84659000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1801000
CY2021Q4	us-gaap	Goodwill Goodwill	62649000
CY2020Q4	us-gaap	Goodwill Goodwill	0
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19240000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19387000
CY2021Q4	dnmr	Leverage Loans Receivable LeverageLoansReceivable	13408000
CY2020Q4	dnmr	Leverage Loans Receivable LeverageLoansReceivable	13408000
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	481000
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2316000
CY2021Q4	dnmr	Loan Fees LoanFees	1397000
CY2020Q4	dnmr	Loan Fees LoanFees	0
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	224000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	111000
CY2021Q4	us-gaap	Assets Assets	838597000
CY2020Q4	us-gaap	Assets Assets	546201000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20790000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10610000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18777000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9220000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	214000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2455000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3337000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3000000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	357000
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	25201000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	43475000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	50486000
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	9578000
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	82860000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22693000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24175000
CY2021Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	260934000
CY2020Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	31386000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1014000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	638000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1250000
CY2021Q4	us-gaap	Liabilities Liabilities	338332000
CY2020Q4	us-gaap	Liabilities Liabilities	190157000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100687820
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100687820
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84535640
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84535640
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	8000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	619145000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	414819000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-118890000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58783000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	500265000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	356044000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	838597000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	546201000
CY2021	us-gaap	Revenues Revenues	58749000
CY2020	us-gaap	Revenues Revenues	47333000
CY2019	us-gaap	Revenues Revenues	32344000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	57865000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	35876000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	21237000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	80004000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19343000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16027000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20270000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7851000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5482000
CY2021	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-82000
CY2020	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	9000
CY2019	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	281000
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0
CY2019	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-8000000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	158221000
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	63061000
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	50465000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-99472000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-15728000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-18121000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-27767000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3720000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-763000
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2080000
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3135000
CY2021	dnmr	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	1776000
CY2020	dnmr	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	5266000
CY2019	dnmr	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	5550000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2604000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-44000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-31000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	277000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	26132000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6875000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2692000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-73340000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8853000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15429000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13233000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4085000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-60107000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-8853000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-19514000
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.65
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.77
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	93078004
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29570658
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	25335298
CY2020	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	22844000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	500265000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	356044000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	16576000
CY2021	us-gaap	Profit Loss ProfitLoss	-60107000
CY2020	us-gaap	Profit Loss ProfitLoss	-8853000
CY2019	us-gaap	Profit Loss ProfitLoss	-19514000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-27767000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3720000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	55270000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	3645000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	5271000
CY2021	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	11674000
CY2020	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	4609000
CY2019	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	3507000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13233000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4137000
CY2021	dnmr	Loss On Writeoff Of Deferred Loan Costs LossOnWriteoffOfDeferredLoanCosts	1939000
CY2020	dnmr	Loss On Writeoff Of Deferred Loan Costs LossOnWriteoffOfDeferredLoanCosts	0
CY2019	dnmr	Loss On Writeoff Of Deferred Loan Costs LossOnWriteoffOfDeferredLoanCosts	0
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	480000
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1655000
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1511000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1040000
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	514000
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	562000
CY2021	dnmr	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	1776000
CY2020	dnmr	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	5266000
CY2019	dnmr	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	5550000
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-82000
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	9000
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	281000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-389000
CY2021	dnmr	Interest Incurred But Not Paid InterestIncurredButNotPaid	0
CY2020	dnmr	Interest Incurred But Not Paid InterestIncurredButNotPaid	809000
CY2019	dnmr	Interest Incurred But Not Paid InterestIncurredButNotPaid	0
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10835000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1600000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2195000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9799000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6604000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2993000
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	4336000
CY2020	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	2392000
CY2019	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	263000
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2110000
CY2020	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	708000
CY2019	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	757000
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	75000
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-5000
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	73000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2048000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	993000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3635000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1526000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	5250000
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	7360000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2241000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2125000
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-420000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-62963000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13797000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1673000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	185411000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38268000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	36560000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	151179000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	422000
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	9000
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	875000
CY2021	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	0
CY2020	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	0
CY2019	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	13408000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-336168000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38259000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-49093000
CY2021	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	240245000
CY2020	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	4547000
CY2019	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	48251000
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	138196000
CY2020	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0
CY2019	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0
CY2021	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	0
CY2020	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	403702000
CY2019	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	0
CY2021	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	35040000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	27162000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1941000
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15222000
CY2021	dnmr	Increase Decrease Transacttion Costs Related To Business Combination And Pipe Offering IncreaseDecreaseTransacttionCostsRelatedToBusinessCombinationAndPIPEOffering	0
CY2020	dnmr	Increase Decrease Transacttion Costs Related To Business Combination And Pipe Offering IncreaseDecreaseTransacttionCostsRelatedToBusinessCombinationAndPIPEOffering	-21556000
CY2019	dnmr	Increase Decrease Transacttion Costs Related To Business Combination And Pipe Offering IncreaseDecreaseTransacttionCostsRelatedToBusinessCombinationAndPIPEOffering	0
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	10424000
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	135000
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4681000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1728000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2899000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5540000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-890000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	32518000
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8752000
CY2021	dnmr	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	106000
CY2020	dnmr	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	0
CY2019	dnmr	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	0
CY2021	dnmr	Increase Decrease Proceeds From Hedge Financing Activities IncreaseDecreaseProceedsFromHedgeFinancingActivities	0
CY2020	dnmr	Increase Decrease Proceeds From Hedge Financing Activities IncreaseDecreaseProceedsFromHedgeFinancingActivities	0
CY2019	dnmr	Increase Decrease Proceeds From Hedge Financing Activities IncreaseDecreaseProceedsFromHedgeFinancingActivities	21000000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4602000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	306202000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	422675000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53498000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-92929000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	370619000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2732000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	379897000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9278000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6546000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	286968000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	379897000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9278000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2021Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000
CY2021Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	400000
CY2020Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	500000
CY2020Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	1800
CY2021	us-gaap	Advertising Costs Policy Capitalized Direct Response Advertising AdvertisingCostsPolicyCapitalizedDirectResponseAdvertising	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Advertising Costs</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We charge advertising costs to selling, general and administrative expense as incurred. Advertising costs were not material during 2021, 2020 or 2019.</span></p>
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	500000
CY2020	us-gaap	Interest Expense Other InterestExpenseOther	1000000.0
CY2019	us-gaap	Interest Expense Other InterestExpenseOther	1300000
CY2020Q4	dnmr	Reverse Acquisition Exchange Rate ReverseAcquisitionExchangeRate	9.158
CY2021Q1	dnmr	Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsgrantdatefairvalue Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsgrantdatefairvalue	36.57
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0151
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P9Y9M18D
CY2021	dnmr	Aggregate Value aggregateValue	397300000
CY2021	dnmr	Warrants Of Purchase Shares WarrantsOfPurchaseShares	6315924
CY2021	us-gaap	Business Acquisition Pro Forma Information Description BusinessAcquisitionProFormaInformationDescription	The Legacy Danimer shareholders are entitled to receive up to an additional 6,000,000 shares of our common stock (“Earnout Shares”) if the volume-weighted average price (“VWAP”) of our shares equals or exceeds the following prices for any 20 trading days within any 30 trading-day period (“Trading Period”) beginning on June 29, 2021:
CY2021Q4	dnmr	Additional Earnout Shares Entitled AdditionalEarnoutSharesEntitled	6000000
CY2020	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	47362000
CY2021	dnmr	Proforma Business Combination Loss From Operations ProformaBusinessCombinationLossFromOperations	-101986000
CY2020	dnmr	Proforma Business Combination Loss From Operations ProformaBusinessCombinationLossFromOperations	-28751000
CY2020Q4	us-gaap	Business Acquisition Pro Forma Information Description BusinessAcquisitionProFormaInformationDescription	On December 29, 2020, the fair value of the 6,000,000 Earnout Shares was $140.9 million. We reflected the Earnout Shares at December 31, 2020 as a stock dividend by reducing additional paid-in capital, which was offset by the increase in additional paid-in capital associated with the Business Combination.
CY2020Q4	dnmr	Additional Earnout Shares Fair Value AdditionalEarnoutSharesFairValue	140900000
CY2021Q3	dnmr	Earnout Shares Issued EarnoutSharesIssued	2499993
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	2741000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	2741000
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	15591000
CY2021Q4	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Property Plant And Equipment BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment	3031000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	18622000
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	2285000
CY2021Q4	dnmr	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Other Assets Acquired BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsAcquired	17000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	2302000
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	2000000
CY2021Q4	dnmr	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Right Of Use Assets Acquired BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRightOfUseAssetsAcquired	715000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	2715000
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	85400000
CY2021Q4	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles	1000000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	84400000
CY2021Q3	us-gaap	Goodwill Goodwill	66581000
CY2021Q4	dnmr	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Goodwill BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill	3932000
CY2021Q4	us-gaap	Goodwill Goodwill	62649000
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	16159000
CY2021Q4	dnmr	Business Combination Provisional Information Initial Accounting Incomplete Adjustments Deferred Tax Liability BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsDeferredTaxLiability	1913000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	14246000
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities	2000000
CY2021Q4	dnmr	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Lease Liability BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLeaseLiability	759000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities	2759000
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	2019000
CY2021Q4	dnmr	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Liabilities Assumed BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed	15000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	2004000
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contingent Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability	-500000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contingent Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability	-500000
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	153920000
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	153920000
CY2020	dnmr	Business Acquisition Proforma Adjustments Transaction Costs BusinessAcquisitionProformaAdjustmentsTransactionCosts	2600000
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	58783000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	11555000
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6825000
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	928000
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	133000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	12090000
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6684000
CY2021Q4	us-gaap	Inventory Net InventoryNet	24573000
CY2020Q4	us-gaap	Inventory Net InventoryNet	13642000
CY2021Q4	dnmr	Finished Neat Pha Included In Finished Goods FinishedNeatPhaIncludedInFinishedGoods	5600000
CY2020Q4	dnmr	Finished Neat Pha Included In Finished Goods FinishedNeatPhaIncludedInFinishedGoods	3000000.0
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	345363000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	126426000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	29182000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19631000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	316181000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106795000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P16Y6M
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11674000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4609000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3507000
CY2021Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	5700000
CY2020Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	5100000
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	600000
CY2020	us-gaap	Interest Costs Incurred InterestCostsIncurred	3700000
CY2021	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P19Y9M18D
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	93244000
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8297000
CY2021Q4	dnmr	Intangible Assets Not Yet Amortized IntangibleAssetsNotYetAmortized	869000
CY2020Q4	dnmr	Intangible Assets Not Yet Amortized IntangibleAssetsNotYetAmortized	469000
CY2021Q4	dnmr	Amortization Intangible Assets Gross AmortizationIntangibleAssetsGross	92375000
CY2020Q4	dnmr	Amortization Intangible Assets Gross AmortizationIntangibleAssetsGross	7828000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-8585000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-6496000
CY2021Q4	dnmr	Amortization Intangible Assets Net AmortizationIntangibleAssetsNet	83790000
CY2020Q4	dnmr	Amortization Intangible Assets Net AmortizationIntangibleAssetsNet	1332000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	84659000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1801000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4728000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4564000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4229000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4229000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4229000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	61811000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	83790000
CY2020Q4	us-gaap	Goodwill Goodwill	0
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	62649000
CY2021Q4	us-gaap	Goodwill Goodwill	62649000
CY2018	dnmr	Operating Lease Purchase Price OperatingLeasePurchasePrice	23000000.0
CY2018	us-gaap	Sale Leaseback Transaction Other Payments Required SaleLeasebackTransactionOtherPaymentsRequired	30000000.0
CY2018Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P20Y
CY2018Q4	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P20Y
CY2018	dnmr	Rent Increase RentIncrease	2400000
CY2021	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The rent is subject to an adjustment of the lesser of (i) 2.0% or (ii) 1.25 times the change in the Consumer Price Index on January 1, 2020, and annually on every January 1st thereafter during the lease term, including any extension terms. The renewal terms have not been recognized as part of the right-of-use asset and lease liability since we have not determined that their exercise is reasonably certain. We used our estimated 2018 incremental borrowing rate of 12.89% when determining the discount rate for the lease
CY2018	dnmr	Incremental Borrowing Rate Percentage IncrementalBorrowingRatePercentage	0.1289
CY2020Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	7300000
CY2020Q2	dnmr	Rent Increase RentIncrease	3100000
CY2020Q2	dnmr	Incremental Borrowing Rate Percentage IncrementalBorrowingRatePercentage	0.115
CY2020Q2	dnmr	Increased In Right Of Use Asset And Lease Liability IncreasedInRightOfUseAssetAndLeaseLiability	7100000
CY2021Q4	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P17Y
CY2021Q3	dnmr	Incremental Borrowing Rate Percentage IncrementalBorrowingRatePercentage	0.115
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2700000
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2700000
CY2021Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P6Y
CY2021Q3	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P5Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P18Y
CY2021	dnmr	Operating Lease Expense Benefit Net OperatingLeaseExpenseBenefitNet	2488000
CY2020	dnmr	Operating Lease Expense Benefit Net OperatingLeaseExpenseBenefitNet	3620000
CY2019	dnmr	Operating Lease Expense Benefit Net OperatingLeaseExpenseBenefitNet	3135000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	3543000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	3545000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	3548000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	3550000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	3553000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	40403000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	58142000
CY2021Q4	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	32112000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	26030000
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	7600000
CY2021Q4	dnmr	Construction In Progress Accrued Liabilities ConstructionInProgressAccruedLiabilities	8896000
CY2020Q4	dnmr	Construction In Progress Accrued Liabilities ConstructionInProgressAccruedLiabilities	531000
CY2021Q4	dnmr	Accrued Compensation And Related Liabilities AccruedCompensationAndRelatedLiabilities	4572000
CY2020Q4	dnmr	Accrued Compensation And Related Liabilities AccruedCompensationAndRelatedLiabilities	5395000
CY2021Q4	dnmr	Loss On Supply Contract Accrued Liabilities LossOnSupplyContractAccruedLiabilities	1423000
CY2020Q4	dnmr	Loss On Supply Contract Accrued Liabilities LossOnSupplyContractAccruedLiabilities	0
CY2021Q4	dnmr	Accrued Legal Settlement Liabilities AccruedLegalSettlementLiabilities	1250000
CY2020Q4	dnmr	Accrued Legal Settlement Liabilities AccruedLegalSettlementLiabilities	1250000
CY2021Q4	dnmr	Transaction Costs And Other Legal Fees TransactionCostsAndOtherLegalFees	850000
CY2020Q4	dnmr	Transaction Costs And Other Legal Fees TransactionCostsAndOtherLegalFees	1293000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1786000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	751000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18777000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9220000
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3914525
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6000000
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	271854000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	60542000
CY2021Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	10563000
CY2020Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	3955000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	357000
CY2021Q4	dnmr	Purchase Of Capped Call Options PurchaseOfCappedCallOptions	35000000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	39408796
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27794856
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7092014
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	25201000
CY2021Q4	dnmr	Long Term Debt Net Of Current Maturities And Debt Issuance Costs LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts	260934000
CY2020Q4	dnmr	Long Term Debt Net Of Current Maturities And Debt Issuance Costs LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts	31386000
CY2021Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	4000000.0
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	11800000
CY2021Q4	us-gaap	Capital Expenditure Discontinued Operations CapitalExpenditureDiscontinuedOperations	1000000.0
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	357000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	108000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	10275000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	42000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	240043000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	21029000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	271854000
CY2020Q4	us-gaap	Share Price SharePrice	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84535640
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	16000000
CY2020	dnmr	Converted Shares ConvertedShares	1686507
CY2020Q4	us-gaap	Non Recourse Debt NonRecourseDebt	28800000
CY2019Q4	us-gaap	Non Recourse Debt NonRecourseDebt	27700000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84535640
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25371186
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	16152180
CY2020	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	59164454
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100687820
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84535640
CY2021	us-gaap	Dividends Dividends	0
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	800000
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	200000
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2500000
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1500000
CY2021	us-gaap	Revenues Revenues	58749000
CY2020	us-gaap	Revenues Revenues	47333000
CY2019	us-gaap	Revenues Revenues	32344000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	55908000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	3645000
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	5271000
CY2021Q1	dnmr	Restricted Stock Shares RestrictedStockShares	1517836
CY2021Q1	dnmr	Additional Restricted Stock Shares Granted AdditionalRestrictedStockSharesGranted	1517840
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11141491
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.00
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M28D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28500630000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6089669
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	22.46
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6209331
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.48
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	13296
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.28
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11008533
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.94
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P8Y4M17D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	105341482000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	335896
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	19.32
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	723369
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.31
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	23188428000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	32050
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10589010
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.85
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P7Y4M20D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22473835000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4463758
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.79
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y2M23D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	21436151000
CY2021Q4	dnmr	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Number Of Shares Vested And Expected To Vest ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedNumberOfSharesVestedAndExpectedToVest	10589010
CY2021Q4	dnmr	Weighted Average Exercise Price Vested And Expected To Vest WeightedAverageExercisePriceVestedAndExpectedToVest	14.85
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y4M20D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	22473835000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	8.40
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	8.91
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.13
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	113700000
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13200000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-52000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-52000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-14601000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2134000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2021	dnmr	Federal Valuation Allowance FederalValuationAllowance	-3139000
CY2020	dnmr	Federal Valuation Allowance FederalValuationAllowance	-2134000
CY2019	dnmr	Federal Valuation Allowance FederalValuationAllowance	-3218000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1649000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-463000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	dnmr	State Valuation Allowance StateValuationAllowance	122000
CY2020	dnmr	State Valuation Allowance StateValuationAllowance	-463000
CY2019	dnmr	State Valuation Allowance StateValuationAllowance	-919000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13233000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4137000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13233000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4085000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-15401000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1859000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3211000
CY2021	dnmr	Permanentdifferenceassociatedwithgainonremeasurementofprivatewarrants Permanentdifferenceassociatedwithgainonremeasurementofprivatewarrants	-5831000
CY2020	dnmr	Permanentdifferenceassociatedwithgainonremeasurementofprivatewarrants Permanentdifferenceassociatedwithgainonremeasurementofprivatewarrants	-781000
CY2019	dnmr	Permanentdifferenceassociatedwithgainonremeasurementofprivatewarrants Permanentdifferenceassociatedwithgainonremeasurementofprivatewarrants	0
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1307000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-573000
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-725000
CY2021	dnmr	Income Tax Reconciliation Deductions Transaction Costs Associated With The Business Combination IncomeTaxReconciliationDeductionsTransactionCostsAssociatedWithTheBusinessCombination	475000
CY2020	dnmr	Income Tax Reconciliation Deductions Transaction Costs Associated With The Business Combination IncomeTaxReconciliationDeductionsTransactionCostsAssociatedWithTheBusinessCombination	-220000
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-1744000
CY2020	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	662000
CY2019	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-1003000
CY2021	dnmr	Income Tax Reconciliation Deductions Stockbased Compensation IncomeTaxReconciliationDeductionsStockbasedCompensation	474000
CY2020	dnmr	Income Tax Reconciliation Deductions Stockbased Compensation IncomeTaxReconciliationDeductionsStockbasedCompensation	157000
CY2019	dnmr	Income Tax Reconciliation Deductions Stockbased Compensation IncomeTaxReconciliationDeductionsStockbasedCompensation	0
CY2021	dnmr	Income Tax Reconciliation Deductions Other Permanent Differences IncomeTaxReconciliationDeductionsOtherPermanentDifferences	11000
CY2020	dnmr	Income Tax Reconciliation Deductions Other Permanent Differences IncomeTaxReconciliationDeductionsOtherPermanentDifferences	17000
CY2019	dnmr	Income Tax Reconciliation Deductions Other Permanent Differences IncomeTaxReconciliationDeductionsOtherPermanentDifferences	18000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3000
CY2021	dnmr	Officers Salary162 M Limitation OfficersSalary162MLimitation	7291000
CY2020	dnmr	Officers Salary162 M Limitation OfficersSalary162MLimitation	0
CY2019	dnmr	Officers Salary162 M Limitation OfficersSalary162MLimitation	0
CY2021	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	373000
CY2020	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0
CY2019	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	155000
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	0
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	0
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3017000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2597000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	9003000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13233000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4085000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39408000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16614000
CY2021Q4	dnmr	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	5953000
CY2020Q4	dnmr	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	6921000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	3652000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1061000
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	577000
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0
CY2021Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	34000
CY2020Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	89000
CY2021Q4	dnmr	Legal Settlement Accrual Legal Settlement Accrual LegalSettlementAccrualLegalSettlementAccrual	286000
CY2020Q4	dnmr	Legal Settlement Accrual Legal Settlement Accrual LegalSettlementAccrualLegalSettlementAccrual	637000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	49000
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	625000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	120000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	33000
CY2021Q4	dnmr	Tax Credit TaxCredit	992000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	0
CY2021Q4	dnmr	Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation	65000
CY2020Q4	dnmr	Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation	0
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	325000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	143000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	51461000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	26123000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25179000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19050000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	26282000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7073000
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	4400000
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	4938000
CY2021Q4	dnmr	Deferred Tax Liabilities Deferred Expense Depreciation And Amortization DeferredTaxLiabilitiesDeferredExpenseDepreciationAndAmortization	22896000
CY2020Q4	dnmr	Deferred Tax Liabilities Deferred Expense Depreciation And Amortization DeferredTaxLiabilitiesDeferredExpenseDepreciationAndAmortization	2135000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	27296000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	24000
CY2021	dnmr	Changes In Accounts Payable And Accrued Liabilities Related To Purchase Of Property Plant And Equipment ChangesInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfPropertyPlantAndEquipment	16103000
CY2020	dnmr	Changes In Accounts Payable And Accrued Liabilities Related To Purchase Of Property Plant And Equipment ChangesInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfPropertyPlantAndEquipment	533000
CY2019	dnmr	Changes In Accounts Payable And Accrued Liabilities Related To Purchase Of Property Plant And Equipment ChangesInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfPropertyPlantAndEquipment	6318000
CY2020	dnmr	Forgiveness Of Nmtc Leverage Loan Receivable ForgivenessOfNmtcLeverageLoanReceivable	14334000
CY2019	dnmr	Forgiveness Of Nmtc Leverage Loan Receivable ForgivenessOfNmtcLeverageLoanReceivable	20478000
CY2021	dnmr	Forgiveness Of Debt ForgivenessOfDebt	1776000
CY2020	dnmr	Forgiveness Of Debt ForgivenessOfDebt	20000000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7073000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1014000
CY2019Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	16453000
CY2020	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	0
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2597000
CY2020	dnmr	Deferred Tax Assets Valuation Allowance Amounts Utilized DeferredTaxAssetsValuationAllowanceAmountsUtilized	0
CY2020Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	19050000
CY2020Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	19050000
CY2021	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	3112000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3017000
CY2021	dnmr	Deferred Tax Assets Valuation Allowance Amounts Utilized DeferredTaxAssetsValuationAllowanceAmountsUtilized	0
CY2021Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	25179000
CY2021	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	0
CY2020	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	0
CY2019	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	0
CY2021	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	0
CY2020	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	0
CY2019	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	0
CY2021Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	0
CY2020Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	0
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	1
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.04
CY2021	dnmr	Defined Contribution Plan Matching Expense DefinedContributionPlanMatchingExpense	500000
CY2020	dnmr	Defined Contribution Plan Matching Expense DefinedContributionPlanMatchingExpense	300000
CY2019	dnmr	Defined Contribution Plan Matching Expense DefinedContributionPlanMatchingExpense	200000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	512000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1450000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	1964000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	3346000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	2950000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	2875000
CY2019	dnmr	Forgiveness Of Debt ForgivenessOfDebt	26069000
CY2020	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	11723000
CY2020	dnmr	Transaction Costs In Accounts Payable And Accrued Expenses TransactionCostsInAccountsPayableAndAccruedExpenses	1288000
CY2020	dnmr	Accounts Payable Settled Directly By Landlord AccountsPayableSettledDirectlyByLandlord	1082000
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	524000
CY2020	dnmr	Private Warrant Liability Assumed In Business Combination PrivateWarrantLiabilityAssumedInBusinessCombination	86580000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	286487000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	377581000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6261000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	481000
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	2316000
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	3017000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	286968000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	379897000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9278000
CY2021	dnmr	Royalty Per Share RoyaltyPerShare	0.05
CY2021	dnmr	Weights Of Pha Sold WeightsOfPhaSold	500000000
CY2021	dnmr	Decrease Royalty Per Share DecreaseRoyaltyPerShare	0.025
CY2021	us-gaap	Payments For Royalties PaymentsForRoyalties	300000
CY2021	dnmr	Settlement Liabilities Payable Amount SettlementLiabilitiesPayableAmount	8000000
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1250000
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1250000
CY2021Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	0
CY2020Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1250000

Files In Submission

Name	View Source	Status
0000950170-22-003031-index-headers.html	Edgar Link	pending
0000950170-22-003031-index.html	Edgar Link	pending
0000950170-22-003031.txt	Edgar Link	pending
0000950170-22-003031-xbrl.zip	Edgar Link	pending
dnmr-20211231.htm	Edgar Link	pending
dnmr-20211231.xsd	Edgar Link	pending
dnmr-20211231_cal.xml	Edgar Link	unprocessable
dnmr-20211231_def.xml	Edgar Link	unprocessable
dnmr-20211231_htm.xml	Edgar Link	completed
dnmr-20211231_lab.xml	Edgar Link	unprocessable
dnmr-20211231_pre.xml	Edgar Link	unprocessable
dnmr-ex10_37.htm	Edgar Link	pending
dnmr-ex21_1.htm	Edgar Link	pending
dnmr-ex23_1.htm	Edgar Link	pending
dnmr-ex23_2.htm	Edgar Link	pending
dnmr-ex31_1.htm	Edgar Link	pending
dnmr-ex31_2.htm	Edgar Link	pending
dnmr-ex32_1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img132551863_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DNMR
Danimer Scientific, Inc. Stock $dnmr

2022 Q1 Form 10-K Financial Statement

#000095017022003031 Filed on March 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DNMR Danimer Scientific, Inc. Stock $dnmr

2022 Q1 Form 10-K Financial Statement

#000095017022003031 Filed on March 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DNMR
Danimer Scientific, Inc. Stock $dnmr